08/01/2024 11:15 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form EFFECT | |
08/01/2024 11:15 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form EFFECT | |
08/01/2024 11:15 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form EFFECT | |
08/01/2024 11:15 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form EFFECT | |
07/19/2024 8:22 AM | eFFECTOR Therapeutics, Inc. (Subject) eFFECTOR Therapeutics, Inc. (Subject) eFFECTOR Therapeutics (Subject) Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
06/25/2024 7:30 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 4:16 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
06/24/2024 6:06 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/13/2024 5:45 PM | eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 5:45 PM | eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics (Issuer) Loewy Caroline M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 5:23 PM | eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics (Issuer) Harrington-Smith Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 5:25 PM | eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics (Issuer) Ehrlich Christopher B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 5:35 PM | eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics (Issuer) Klencke Barbara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 5:15 PM | Bhatt Elizabeth (Reporting) eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 5:19 PM | eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics (Issuer) Gallagher Brian M. Jr. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 7:36 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 3:51 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form 424B3 | |
05/09/2024 3:06 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 3:08 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/26/2024 5:05 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024 5:10 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form DEFA14A | |
04/26/2024 5:14 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form ARS | |
04/16/2024 7:00 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form PRE 14A | |
04/04/2024 7:38 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/04/2024 7:40 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form 424B3 | |
04/04/2024 7:15 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form 424B5 | |
04/02/2024 11:15 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form EFFECT | |
03/29/2024 1:51 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form POS AM | |
03/28/2024 3:02 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/26/2024 7:57 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/25/2024 3:10 PM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/21/2024 4:39 PM | eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics (Issuer) Loewy Caroline M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 4:20 PM | eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics (Issuer) Harrington-Smith Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 4:22 PM | eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics (Issuer) Klencke Barbara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 4:25 PM | eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics (Issuer) Ehrlich Christopher B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 4:27 PM | Bhatt Elizabeth (Reporting) eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics, Inc. (Issuer) eFFECTOR Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 2:48 PM | eFFECTOR Therapeutics, Inc. (Subject) eFFECTOR Therapeutics, Inc. (Subject) eFFECTOR Therapeutics (Subject) PFIZER INC (Filed by)
| Form SC 13G/A | |
02/14/2024 8:48 AM | eFFECTOR Therapeutics, Inc. (Subject) eFFECTOR Therapeutics, Inc. (Subject) eFFECTOR Therapeutics (Subject) SECTORAL ASSET MANAGEMENT INC (Filed by)
| Form SC 13G/A | |
02/09/2024 7:14 PM | eFFECTOR Therapeutics, Inc. (Subject) eFFECTOR Therapeutics, Inc. (Subject) eFFECTOR Therapeutics (Subject) SR ONE CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
01/30/2024 7:31 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2024 7:01 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
DeFi Coin on Verge of Breakout! (Ad) The blueprint for millionaires is here.
Don't let this be the missed opportunity you regret for years.
Claim your FREE book now before it's too late! |
01/10/2024 7:06 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form 424B3 | |
01/08/2024 7:19 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form 424B3 | |
01/08/2024 7:15 AM | eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics, Inc. (Filer) eFFECTOR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |